Brett D. Gurden, PA-C

Brett Gurden practices at Laboratory Corporation of America in Zephyrhills, Florida.

Brett Gurden's NPI, 1124544036, was assigned on August 22, 2017. Brett Gurden graduated from Indiana University School of Medicine in 2017. Brett Gurden holds Michigan license 5601008627.

Brett Gurden's primary practice is Laboratory Corporation of America, at 5611 St, Zephyrhills, FL 33542 in Pasco County. The practice phone is (800) 877-5227.

Brett Gurden's primary practice is Laboratory Corporation of America in Zephyrhills, Florida. Brett Gurden is also affiliated with Memorial Healthcare. The medical group on file is The Villages Health. Dmand AI also links Brett Gurden to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Brett Gurden practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Brett Gurden's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Dmand AI has Brett Gurden's licenses on file in 3 states: Michigan, Florida and Indiana.

Dmand AI lists acute skin infection, alzheimer's disease, anxiety, arthritis, asthma, bipolar disorder, chronic kidney disease and chronic obstructive pulmonary disease (COPD) among the conditions Brett Gurden treats.

CMS data shows 158 Medicare services from Brett Gurden across 3 procedure codes in 2024, for 105 Medicare patients. Medicare paid $9,962 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 105 Medicare patients who saw Brett Gurden in 2024. The largest group is 65 to 74, with 47 patients. 68% of them have high blood pressure, and 68% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Brett Gurden's median patient age at 73, with 57% women.

In 2024, Brett Gurden wrote 3,718 Medicare Part D claims for 406 patients. 85% of them were for generic drugs. CMS names the drug for 3,040 of them, across 83 drugs with 11 or more claims each, at $270,005 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Brett Gurden for performance year 2024, reported as part of a group. Brett Gurden accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Brett Gurden from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $153.

Brett Gurden graduated from Indiana University School of Medicine in 2017.